Product Launch Details
Wanbury Skin Health Limited, a subsidiary of Wanbury Limited, has launched its berrysoft™ baby product range across multiple states in India. This launch marks the company's strategic entry into the pediatric dermatology segment.
Product Portfolio
The berrysoft™ baby range addresses everyday baby skincare and hygiene needs with the following products:
- Gentle Bathing Bar (launched)
- Gentle Body Wash (launched)
- Foam Shampoo (launched)
- Syndet Handwash (launched)
- Moisturising Lotion (in pipeline)
- Diaper Rash Cream (in pipeline)
- Moisturising Cream (in pipeline)
The range features dedicated formulations for different aspects of a baby's daily cleansing, moisturization, and skincare routine.
Regulatory Approvals and Geographic Expansion
The company has received GST registration in 5 states including Maharashtra, Delhi, and Karnataka, with three more states in the pipeline. Additionally, the company has received CFA Drug Licenses in Mumbai, Jaipur, Patna, and Ambala, with four more locations in the pipeline.
Strategic Rationale
The launch leverages Wanbury Limited's existing relationships with pediatricians (doctors specialized in children's practice). The company already markets cold and cough products to this customer base and will use cross-selling opportunities to extend engagement with pediatricians. Wanbury Skin Health Limited will also focus on building relationships with dermatologists to strengthen its presence in the dermatology segment.
Corporate Strategy Context
This initiative reflects Wanbury Limited's focus on expanding its overall healthcare portfolio through its various subsidiaries. Wanbury Skin Health Limited specifically focuses on dermatology solutions for children and adults. The company aims to drive growth in complementary product categories and strengthen its presence across relevant healthcare segments by leveraging established market relationships.
Strategic Significance
The multi-state launch represents an important milestone in Wanbury Limited's growth strategy, combining portfolio diversification with deeper engagement across its existing healthcare professional network. The company will continue to explore opportunities to broaden its product portfolio and strengthen its presence across relevant healthcare categories.